Viewing Study NCT00393094

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2026-03-27 @ 11:51 AM
Study NCT ID: NCT00393094
Status: TERMINATED
Last Update Posted: 2012-07-13
First Post: 2006-10-25
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Bevacizumab and Irinotecan to Treat Brain Tumors
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None High-Grade Gliomas View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Brain Tumor View
None Chemotherapy View
None Progression View
None Radiotherapy View
None Antiangiogenesis View
None Glioma View